The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial

BACKGROUND: Angiotensin-converting enzyme inhibitors and the angiotensin-receptor blocker valsartan ameliorate ventricular remodeling after myocardial infarction (MI). Based on previous clinical trials, a maximum clinical dose is recommended in practical guidelines. Yet, has not been clearly demonst...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Young-Rak, Kim, Young-Dae, Park, Tae-Ho, Park, Kyungil, Park, Jong-Sung, Baek, Heekyung, Choi, Sun-Young, Kim, Kee-Sik, Hong, Taek-Jong, Yang, Tae-Hyun, Hwang, Jin-Yong, Park, Jong-Seon, Hur, Seung-Ho, Lee, Sang-Gon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247852/
https://www.ncbi.nlm.nih.gov/pubmed/22108275
http://dx.doi.org/10.1186/1745-6215-12-247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247852/
https://www.ncbi.nlm.nih.gov/pubmed/22108275
http://dx.doi.org/10.1186/1745-6215-12-247

Ejemplares similares